EcoDrugPlus

Retinoic Acid Receptor Gamma-A-Like

Ensembl ID : ENSAOCG00000005103
Gene Symbol: LOC111587630
3 Cross references
367 Possible Orthologues:

Rho-Associated Protein Kinase 2-Like

Ensembl ID : ENSAOCG00000015667
Gene Symbol: LOC111566441
3 Cross references
214 Possible Orthologues:

Ribosomal Protein L10

Ensembl ID : ENSAOCG00000018987
Gene Symbol: RPL10
3 Cross references
407 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSAOCG00000013690
Gene Symbol: RPL10A
3 Cross references
380 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSAOCG00000002035
Gene Symbol: RPL11
3 Cross references
288 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSAOCG00000014635
Gene Symbol: RPL13
3 Cross references
273 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSAOCG00000002123
Gene Symbol: RPL13A
3 Cross references
370 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSAOCG00000012405
Gene Symbol: RPL14
3 Cross references
310 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSAOCG00000013835
Gene Symbol: RPL15
3 Cross references
376 Possible Orthologues:

Ribosomal Protein L17

Ensembl ID : ENSAOCG00000014751
Gene Symbol: RPL17
3 Cross references
324 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSAOCG00000008479
Gene Symbol: RPL18
3 Cross references
379 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSAOCG00000022332
Gene Symbol: RPL18A
3 Cross references
367 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).